Webinar: Effective Gadolinium Reduction with the New High- Relaxivity Gadopiclenol in CNS

Webinar Effective Gadolinium Reduction with the New High-Relaxivity Gadopiclenol in CNS 15 January 2025 6:00-7:00 pm CET @media screen and (min-width: 768px) {.layout--twocol-section--50-50 .layout__region--first .block.block-layout-builder.block-text {padding-right:0px!important; padding-left:60px!important;} .layout--twocol-section--50-50 .layout__region--first .block.block-layout-builder.block-text h3 {font-size:3rem!important;} } .article-hero-wrapper h1 {display:none!important;} .layout--twocol-section--50-50.vertical-align-middle .layout__region.layout__region--second { background-image: url(/media/3519); background-repeat: no-repeat; background-size: cover; background-position: right center!important; } @media screen and (max-width: 767px) { .layout__region.layout__region--second { background-image: url(/media/3520)!important; background-position:center!important; } } Join us We are pleased to invite you to our educational webinar REGISTER NOW The faculty is composed by four renowned neuroradiologists Andrea Rossi – Gaslini Hospital, Genoa, Italy Simonetta Gerevini – Papa Giovanni XXIII Hospital, Bergamo, Italy Martin Wiesmann – University Hospital RWTH Aachen, Aachen, Germany Josef Vymazal – Na Homolce Hospital, Prague, Czech Republic Who will be interviewed by the Global Senior Medical Expert of Bracco Gunter Erb . The purpose of the webinar The purpose of the webinar is to take the audience on a journey in CNS MRI , where the speakers will share their knowledge and their clinical experience in diagnosing various neuro-pathologies using the new high-relaxivity contrast agent Gadopiclenol. The benefits of high-relaxivity contrast agents (CAs) and of dose reduction in neuroimaging will be highlighted. Evidence on how high-relaxivity CAs improve CNS lesion detection and facilitate diagnosis will be provided: the speakers will showcase different neuro-pathologies, such as small metastases, high-grade gliomas, demyelinating diseases- e.g multiple sclerosis- and bone metastases, and how the diagnostic can profit from the use of Gadopiclenol. A special focus on pediatric patients will also be addressed. Please accept statistics cookies to view this video. .bg-preview {background-image:url(/media/3522); background-repeat:no-repeat; background-size:cover; background-posizion:center;} .cookieconsent-optout-statistics { border: 1px solid #004c99; padding: 30px; text-transform: uppercase; } @media screen and (max-width: 600px) { .cookieconsent-optout-statistics { padding: 20px; } } The webinar will also feature a live Q&A session , offering you the chance to engage directly with the experts. The webinar will be held in English. Looking forward to see you on January 15. REGISTER NOW

The release as fetched from its publisher. bracco.com ↗